Tag Archives: DERM

Top 10 Clean Energy Stocks To Own Right Now

One of the richest men in China has made a big bet on an icon of Europe’s automotive industry.

Li Shufu, the billionaire chairman of Chinese car maker Geely (GELYF), invested about $9 billion buying a stake of almost 10% in Daimler (DDAIF), making him the biggest single shareholder in the owner of Mercedes Benz.

Li, who’s estimated to be worth around $18 billion, has said he’s not interested in a takeover of Daimler. It’s unclear exactly what he’s after with such a big investment, but he dropped a big hint that the German company’s engineering is central to his vision.

“In order to succeed and seize the technology highland, one has to have friends, partners, and alliances and adapt a new way of thinking in terms of sharing and united strength,” Li said in a statement over the weekend.

Some analysts suggest Li wants to get his hands on Daimler’s clean energy technology. That could help boost Geely’s competitive position in China’s market for electric vehicles, which is already the world’s biggest.

Top 10 Clean Energy Stocks To Own Right Now: Keryx Biopharmaceuticals, Inc.(KERX)

Advisors’ Opinion:

  • [By Keith Speights]

    There were definitely some good parts in what Keryx Biopharmaceuticals (NASDAQ: KERX  ) had to say at this week’s Stifel Nicolaus Weisel Healthcare Conference in Boston. A lot was said, but here are the three highlights you’ll want to know about.

  • [By Lisa Levin]

    Thursday afternoon, the healthcare sector proved to be a source of strength for the market. Leading the sector was strength from Keryx Biopharmaceuticals (NASDAQ: KERX) and Amicus Therapeutics, Inc. (NASDAQ: FOLD).

  • [By Lisa Levin]

    Keryx Biopharmaceuticals (NASDAQ: KERX) shares shot up 14 percent to $5.17 after the company announced positive top-line results from its pivotal Phase 3 study of ferric citrate for the treatment of iron deficiency anemia in adults with non-dialysis dependent chronic kidney disease.

  • [By Lisa Levin]

    Thursday morning, the healthcare sector proved to be a source of strength for the market. Leading the sector was strength from Keryx Biopharmaceuticals (NASDAQ: KERX) and Rockwell Medical Inc (NASDAQ: RMTI).

  • [By Maxx Chatsko]

    While companies with lower-priced shares are often riskier than those with higher prices, some companies trading under $5 per share have intriguing potential. Investors searching for overlooked growth opportunities should consider industrial biotech BioAmber (NYSE:BIOA), pharmaceutical services company Codexis (NASDAQ:CDXS), and one-trick-pony biopharma Keryx Biopharmaceuticals (NASDAQ:KERX).

Top 10 Clean Energy Stocks To Own Right Now: Amphenol Corporation(APH)

Advisors’ Opinion:

  • [By Darren Williams] Although the entire cannabis space has quietly taken a hit of their own medicine in recent weeks and gone to sleep, don’t think for one second the entire space isn’t going to light up again soon. That’s just what they do, right? However, knowing who the pretenders are and knowing who the contenders are is really the challenge when it’s comes right down to it.
    First, anyone who claims to be a grower or a seller of cannabis can’t for one second ever make it as a public company right now, or can even legally consider being a public company for that matter, so you can scratch any of those right off your list. At least here in the U.S. anyway, because Canada is already well ahead of the curve having legalized it for medicinal purposes already.
    More importantly, full legalization of marijuana in Canada appears to be on track for July 2018, which will make Canada just the second nation in the world after Uruguay to completely legalize the cultivation, sale and possession of the drug for medical and recreational purposes.
    Regardless, the best time to buy any stocks in a hot growth sector is when either everyone has forgotten about them, or when the overall market landscape has turned bearish, which has yet to happen. However, the former seems to be the case for the cannabis space, despite some very favorable state legislation last Fall.
    For now, as long as you have a license issued by Health Canada, you’re good to go, so there are some stocks trading in Canada already who are well on their way to making some green for investors. Canopy Growth Corporation (TSE: WEED), formerly Tweed Marijuana Inc., is a medical marijuana company based in Smiths Falls, Ontario. Aurora Cannabis Inc. (CVE: ACB), which is engaged in the production and sale of medical cannabis. There’s also Aphria Pharmaceutical Company (TSE: APH), which also is engaged in producing and selling medical marijuana through retail sales and wholesale channels.
    There are many more, but those are just a
  • [By Lee Jackson]

    This is the top pick in the sector and has remained a favorite at RBC for some time.Amphenol Corp. (NYSE: APH) is one of the worlds largest designers, manufacturers and marketers of electrical, electronic and fiber optic connectors, interconnect systems, antennas, sensors and sensor-based products and coaxial and high-speed specialty cable.

Top 10 Clean Energy Stocks To Own Right Now: Ritchie Bros. Auctioneers Incorporated(RBA)

Advisors’ Opinion:

  • [By Benzinga News Desk]

    Raymond James has downgraded Ritchie Bros. Auctioneers Inc (USA) (NYSE: RBA) common stock to Market Perform

    Loop Capital's Betsy Van Hees sees storage, networking, and connectivity as the 3 reasons why Marvell Technology Group Ltd. (NASDAQ: MRVL) will return to top-Line growth. She reiterated her Buy rating and $18 price target. 

  • [By Max Byerly]

    Ritchie Bros. Auctioneers Inc (NYSE:RBA) (TSE:RBA) – Analysts at Jefferies Group boosted their Q2 2018 earnings estimates for Ritchie Bros. Auctioneers in a report issued on Monday, April 9th. Jefferies Group analyst S. Volkmann now expects that the business services provider will earn $0.39 per share for the quarter, up from their prior forecast of $0.37. Jefferies Group has a “Hold” rating and a $30.00 price target on the stock. Jefferies Group also issued estimates for Ritchie Bros. Auctioneers’ Q3 2018 earnings at $0.16 EPS.

Top 10 Clean Energy Stocks To Own Right Now: Dermira, Inc.(DERM)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Current market dynamics, particularly in the SMID biotech universe, provide a plethora of opportunities for the company to augment the breadth and depth its pipeline in its core therapeutic areas, including neurology, ophthalmology and dermatology, where innovation is rife and where consolidation of some of the smaller players in the space is likely, in our view. Stocks in our SMID coverage universe that could potentially constitute future acquisition targets forAllergan include Aclaris Therapeutics (ACRS) and Dermira (DERM) (both have mid- to late-stage dermatology assets in development). We note with interest the collaboration with Heptares announced yesterday evening for the development of several M1, M4 and dual M1/M4 agonists in development for a variety of neurological diseases, including Alzheimers disease. Notwithstanding this above, larger scale transactions of course cannot be ruled out, and we note todays market commentary (Fox Business) regarding the potential sale of Valeant Pharmaceuticals International’s (VRX) Bausch & Lomb unit. It is reasonable to assume thatAllergan could be a bidder for this asset, given the companys presence in ophthalmology, as well as CEO Brent Saunders familiarity with the asset (he was the CEO prior to its sale toValeant in 2013 for $8.7bn). At the time of its sale to Valeant, B&L was generating c.$3bn in revenues and growing at a double-digit rate. Current sales of the asset are unclear due to the reporting structure of Valeant, as well as concerns regarding the companys operating/ pricing strategy.

  • [By WWW.GURUFOCUS.COM]

    For the details of Novo A’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=Novo+A

    These are the top 5 holdings of Novo AInogen Inc (INGN) – 3,549,320 shares, 59.83% of the total portfolio. Acceleron Pharma Inc (XLRN) – 1,553,937 shares, 9.34% of the total portfolio. Dermira Inc (DERM) – 1,984,364 shares, 7.81% of the total portfolio. Shares added by 3.27%Corvus Pharmaceuticals Inc (CRVS) – 3,244,046 shares, 4.76% of the total portfolio. Akebia Therapeutics Inc (AKBA) – 2,225,000 shares, 4

  • [By Chris Lange]

    Dermira Inc. (NASDAQ: DERM) watched its shares absolutely collapse early on Monday after the firm reported disappointing results from its late-stage trials in patients with acne vulgaris. Essentially, Dermiras Phase 3 trials of the investigational treatment olumacostat glasaretil (formerly DRM01) did not meet the co-primary endpoints.

Top 10 Clean Energy Stocks To Own Right Now: TiVo Inc.(TIVO)

Advisors’ Opinion:

  • [By Lisa Levin]

    TiVo Inc. (NASDAQ: TIVO) shares were also up, gaining 20 percent to $9.22. The New York Times reported that Tivo and Rovi Corporation (NASDAQ: ROVI) are in merger talks.

  • [By Lisa Levin]

    TiVo Inc. (NASDAQ: TIVO) shares were also up, gaining 21 percent to $9.30. The New York Times, citing sources familiar with the issue, said Rovi Corporation (NASDAQ: ROVI) is in advanced negotiations to acquire TiVo. TiVo shareholders would reportedly receive both cash and stock; however, the price tag is yet to be determined.

Top 10 Clean Energy Stocks To Own Right Now: iShares MSCI Europe Financials Sector Index Fund(EUFN)

Advisors’ Opinion:

  • [By Wayne Duggan]

    Investors looking to set up a pair trade to capitalize on the divergent paths of U.S. and European banks should consider going long the iShares Dow Jones US Financial (ETF) (NYSE: IYF) and short the Ishares MSCI Europe Fincls Sctr Indx Fd (NASDAQ: EUFN).

Top 10 Clean Energy Stocks To Own Right Now: Aclaris Therapeutics, Inc.(ACRS)

Advisors’ Opinion:

  • [By Chris Lange]

    Aclaris Therapeutics Inc. (NASDAQ: ACRS) saw its shares make a handy gain on Friday after the company announced the pricing of its secondary offering. The company intends to price its 4 million shares at $22.75 per share, with an overallotment option for an additional 600,000 shares. At this price the entire offering is valued up to $104.65 million.

  • [By Peter Graham]

    Small cap hair loss stocks Aclaris Therapeutics (NASDAQ: ACRS), Cytori Therapeutics (NASDAQ: CYTX) and RepliCel Life Sciences (OTCQB: REPCF; CVE: RP) are trying to tap into a big market as currently, there are only two FDA-approved drugs available for the treatment of Androgenetic Alopecia (AGA) -also known as male or female pattern baldness (one of which cannot be used by women). Thus, a significant unmet need exists for a safe andefficacious product especially since its experienced by 70% of men and 40% of women as they age.

Top 10 Clean Energy Stocks To Own Right Now: Nord Anglia Education, Inc.(NORD)

Advisors’ Opinion:

  • [By Lisa Levin]

    Nord Anglia Education Inc (NASDAQ: NORD) shares shot up 19 percent to $32.83 after the company agreed to be acquired for $32.50 per share in cash.

  • [By Jim Robertson]

    On Monday, our Under the Radar Moversnewsletter suggested going long on small cap international school stock Nord Anglia Education Inc (NYSE: NORD):

Top 10 Clean Energy Stocks To Own Right Now: Great Canadian Gaming Corporation (GCGMF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    Clairvest Group previously initiated an investment in a partnership that involved Great Canadian Gaming Corporation (OTCPK:GCGMF) and Brookfield Business Partners LP to operate two casinos in Southern Ontario. With this announcement, we not only get the upside of a 45% ownership of “Ontario Gaming West GLA Limited Partnership,” which includes four major operations, but also 2,500 slot machines, 60 table games, racing track and $450 million in gross gaming revenue. Clairvest has a history in the gambling industry and Great Canadian Gaming Corporation is a proven operator with a terrific track record.

  • [By SEEKINGALPHA.COM]

    SA: You recently published a thesis on Great Canadian Gaming (OTCPK:GCGMF), a Canadian company do you see the Canadian (or another) market as having greater opportunity to uncover hidden value than the U.S.?

Top 10 Clean Energy Stocks To Own Right Now: Rick’s Cabaret International Inc.(RICK)

Advisors’ Opinion:

  • [By Peter Graham]

    After the market closed yesterday, small cap restaurant and entertainment stockDave & Busters Entertainment Inc (NASDAQ: PLAY) reported Q4 2016 earnings with shares falling by mid single digit percentagesin after hours trading. The Company apparently beat expectations on earnings, but fell short of expectations for comps. Likewise, the stock has already had a very good run meaning expectations were super high.Take a look at the following long term chart which shows Dave & Busters Entertainmentsshare performanceascompared to potential peers such as Buffalo Wild Wings (NASDAQ: BWLD) and upscale gentlemen’s clubs and restaurant ownerRCI Hospitality Holdings, Inc (NASDAQ: RICK):

  • [By Peter Graham]

    A long term performance chart shows Dave & Busters Entertainment being a pretty steady performer up until June while potential peer, upscale gentlemen’s clubs and restaurant ownerRCI Hospitality Holdings, Inc (NASDAQ: RICK), took off last yearand Buffalo Wild Wings (NASDAQ: BWLD) has started to fall off:

  • [By Peter Graham]

    A long term performance chart shows Dave & Busters Entertainment doubling in valuewhile potential peer, small cap upscale gentlemen’s clubs and restaurant ownerRCI Hospitality Holdings, Inc (NASDAQ: RICK), began to takeoff last yearand small capBuffalo Wild Wings (NASDAQ: BWLD) has basically been range bound for the last four days:

Top 10 Casino Stocks To Watch For 2018

Amaya’s stock has been on a wild roller coaster ride this year, with catalysts ranging from the CEO (David Baazov) being accused of insider trading, to takeover rumors, to failed mergers and now a formal bid by the aforementioned CEO. There have certainly been a lot of hopes and headaches, but I believe there is a strong underlining long case to be made on Amaya. I wrote a blog post about it the day before it released its Q3 earnings, my basic argument was that it is intrinsically undervalued due to market overreaction on merger discussions and there was still the possibility of a buyout by the former CEO at a significant upside. It seemed like a win-win. Well, when the earnings were released, not only were the results impressive but Baazov launched a formal bid at C$24 per share (approximately US$18) or a 30% upside from the previous Friday’s Close. Whether this private takeover succeeds or not, this stock is poised for significant long term growth.

Amaya (NASDAQ:AYA) runs the world’s largest online gaming (casino) empire in the world. It runs many valuable brand names especially in the online poker business (PokerStars and Fulltilt) but is now increasingly moving into sports betting and other online casino games. It is also the fastest growing and most well positioned to take advantage of online gambling legalization as well as the inherent scalability of the internet. This is a company which has seen its revenues increase from below US$200M just a few years ago to over US$1.2 BILLION for the trailing twelve months. Reviewing its results and its future growth prospects, it will be clear that this firm is undervalued.

Top 10 Casino Stocks To Watch For 2018: Nemaska Lithium Inc. (NMKEF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    Joe is a fan of Australian-listed Galaxy Resources (GXY on the ASX), acompany with a hard-rock operation in production in Australia, a world-class brine development project (Sal de Vida) in Argentina that has a bank feasibility study on it, and a promising exploration project in Quebec, Canada, near Nemaska’s (OTCQX:NMKEF) Whabouchi project. GXY is up 60% in just the past three months.

  • [By SEEKINGALPHA.COM]

    Nemaska Lithium (OTCQX:NMKEF) provided a project update and announced a C$50 million bought deal with shares selling for C$1.05 a piece. The fresh funds will be put to work at the Whabouchi development project, which appears to be progressing well. Commercial-scale production is expected by Q1 2019.

  • [By SEEKINGALPHA.COM]

    The other producing lithium miners, and soon to be producers. I have discussed these previously in detail here, here and here. Needless to say, the top 3 producers are non-pure plays (SQM (NYSE:SQM), Albemarle (NYSE:ALB), and FMC Corp. (NYSE:FMC)). The top pure play currently producing miners are Orocobre (ASX:ORE) (OTCPK:OROCF), Tianqi Lithium (SHE:002466), Jiangxi Ganfeng Lithium, Galaxy Resources, Mineral Resources [ASX:MIN] (OTC:MALRF), and Neometals [ASX:NMT] (OTC:RRSSF). The near-term producers include Altura Mining [ASX:AJM] (OTCPK:ALTAF), Pilbara Minerals (ASX:PLS) (OTC:PILBF), Kidman Resources (ASX:KDR), Critical Elements, Nemaska Lithium (OTCQX:NMKEF) [TSX:NMX], Lithium Americas (OTCQX:LACDF) [TSX:LAC], Lithium X (OTCQX:LIXXF) (TSXV:LIX), Neo Lithium, and Bacanora Minerals (OTC:BCRMF) [TSXV:BCN], Advantage Lithium (OTCQB:AVLIF) [AAL], European Metals (OTCPK:MNTCF, ASX:EMH, AIM:EMH) and Pure Energy (OTCQB:PEMIF) [PE].

Top 10 Casino Stocks To Watch For 2018: Rockwell Automation, Inc.(ROK)

Advisors’ Opinion:

  • [By Lee Jackson]

    These companies also reported insider selling last week: Aetna Inc. (NYSE: AET), Cullen/Frost Bankers Inc. (NYSE: CFR), Rockwell Automation Inc. (NYSE: ROK), Stamps.com (NASDAQ: STMP) and Western Alliance Bancorporation (NYSE: WAL).

  • [By Paul Ausick]

    Blaming the unwillingness of its target even to discuss a buyout, Emerson Electric Co. (NYSE: EMR) on Tuesday announced that it has withdrawn its unsolicited offer to acquire Rockwell Automation Inc. (NYSE: ROK) for $225 a share in a deal valued at nearly $30 billion.

  • [By Ben Levisohn]

    Bernstein’s Steven Winoker looks back at 2016 for the industrial stocks he covers–Ingersoll-Rand (IR), Rockwell Automation (ROK), Eaton (ETN), and General Electric (GE) among them–and contemplates what 2017 might hold:

Top 10 Casino Stocks To Watch For 2018: First Majestic Silver Corp.(AG)

Advisors’ Opinion:

  • [By Lisa Levin] Related CXW Trump Or Clinton: Who Would Create More Jobs? The 2016 Economics Nobel Prize Winner's Case Against Private Prisons: Contracts Are The Key Wall Street Breakfast: Trump Takes The White House (Seeking Alpha)
    Related SAEX 20 Biggest Mid-Day Losers For Friday 22 Stocks Moving In Friday's Pre-Market Session SAExploration wins $35M seismic data deal (Seeking Alpha)
    Gainers
    Corrections Corp Of America (NYSE: CXW) shares rose 16.3 percent to $16.50 in pre-market trading following Donald Trump's victory.
    SAExploration Holdings, Inc. (NASDAQ: SAEX) shares rose 15.4 percent to $7.26 in pre-market trading after the company reported a new $35 million deep water ocean-bottom marine project award.
    The GEO Group Inc (NYSE: GEO) shares rose 12.9 percent to $26.95 in pre-market trading following Donald Trump's victory.
    Cloud Peak Energy Inc. (NYSE: CLD) rose 12.3 percent to $7.40 in pre-market trading after gaining 0.30 percent on Tuesday.
    Ariad Pharmaceuticals, Inc. (NASDAQ: ARIA) rose 11.7 percent to $10.35 in pre-market trading. Ariad Pharmaceuticals disclosed that its Phase 1/2 trial data on investigational drug brigatinib were published in The Lancet Oncology.
    AK Steel Holding Corporation (NYSE: AKS) rose 11.2 percent to $6.75 in pre-market trading after gaining 3.23 percent on Tuesday.
    Pretium Resources Inc (NYSE: PVG) rose 11 percent to $10.50 in pre-market trading after declining 1.66 percent on Tuesday.
    First Majestic Silver Corp (NYSE: AG) rose 9.3 percent to $8.90 in the pre-market trading session. First Majestic reported Q3 earnings of $0.07 per share on revenue of $79.3 million. Silver futures gained 2.2 percent to $18.77 an ounce.
    Dicerna Pharmaceuticals Inc (NASDAQ: DRNA) rose 9.2 percent to
  • [By Jim Robertson]

    There is no denying that some silver stocks have a problem with the problem beingthe focus on silver. On Monday, some key silver stocks like First Majestic Silver Corp (NYSE: AG) along with solver benchmark the iShares Silver Trust ETF (NYSEARCA: SLV) saw sharper than normal selloffs on an otherwise short trading day. The problem for investors in First Majestic Silver Corp is that its probably the closest thing to a pure play silver stock out there as most other silver miners have long since made aneffort to diversify into gold and other preciousmetals in case silver prices fall off.

Top 10 Casino Stocks To Watch For 2018: Embraer-Empresa Brasileira de Aeronautica(ERJ)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Friday, industrials shares fell by 0.12 percent. Meanwhile, top losers in the sector included Stericycle Inc (NASDAQ: SRCL), down 17 percent, and Embraer SA (ADR) (NYSE: ERJ), down 13 percent.

Top 10 Casino Stocks To Watch For 2018: Euronet Worldwide Inc.(EEFT)

Advisors’ Opinion:

  • [By Peter Graham]

    Small cap Blackhawk Network Holdingshas movedboth sidewaysor slowly upward after its IPO spinoff from Safeway (NYSE: SWY) whilepotential peer of Green Dot Corporation (NYSE: GDOT) is performing betterwhile Euronet Worldwide, Inc (NASDAQ: EEFT) has been a outperformer:

  • [By Peter Graham]

    Small cap Blackhawk Network Holdingshas largely moved sidewaysafter its IPO spinoff from Safeway (NYSE: SWY) whilepotential peer of Green Dot Corporation (NYSE: GDOT) has underperformed and Euronet Worldwide, Inc (NASDAQ: EEFT) has outperformed:

  • [By Ben Levisohn]

    Western Union (WU) soared to the top of the S&P 500 today after MoneyGram International (MGI) received a bid from Euronet Worldwide (EEFT).

    Agence France-Presse/Getty Images

    Shares of Western Union gained 3.5% to $20.27 today, while the S&P 500 fell 0.3% to 2,365.45.MoneyGram International surged 25% to $15.77, while Euronet Worldwide advanced 0.3% to $83.22.

  • [By Peter Graham]

    Blackhawk Network Holdingshas largelymovedsidewaysor slowly upward after its IPO spinoff from Safeway (NYSE: SWY) whilepotential peers like small capGreen Dot Corporation (NYSE: GDOT) and mid capEuronet Worldwide, Inc (NASDAQ: EEFT) have beenoutperformers:

Top 10 Casino Stocks To Watch For 2018: Envision Healthcare Holdings, Inc.(EVHC)

Advisors’ Opinion:

  • [By Paul Ausick]

    Envision Healthcare Corp. (NYSE: EVHC) dropped about 9.3% Tuesday to post a new 52-week low of $43.22 after closing Monday at $47.67. The 52-week high is $74.75. Volume of around 10 million shares traded was about six times the daily average. The company had no specific news.

  • [By Lisa Levin]

    Envision Healthcare Holdings Inc (NYSE: EVHC) shares shot up 211 percent to $70.15. Envision Healthcare and Amsurg Corp (NASDAQ: AMSG) reported the completion of their merger.

  • [By Ben Levisohn]

    Even on a day like today, somebody had to be the worst performer in the S&P 500, and today that somebody is Envision Healthcare (EVHC), which missed earnings forecasts last night.

Top 10 Casino Stocks To Watch For 2018: Guidewire Software, Inc.(GWRE)

Advisors’ Opinion:

  • [By Monica Gerson]

    Guidewire Software Inc (NYSE: GWRE) is estimated to post its quarterly earnings at $0.06 per share on revenue of $92.43 million.

    Analogic Corporation (NASDAQ: ALOG) is projected to post its quarterly earnings at $0.88 per share on revenue of $127.30 million.

  • [By Peter Graham]

    A long term performance chart shows Ebix Inc actually performing well since the end of 2014 while mid cap peer Guidewire Software Inc (NYSE: GWRE) has been outperforming over a longer period of time and small cap Benefitfocus Inc (NASDAQ: BNFT) has underperformed:

Top 10 Casino Stocks To Watch For 2018: Apogee Enterprises, Inc.(APOG)

Advisors’ Opinion:

  • [By WWW.MONEYSHOW.COM]

    Let me introduce you to Apogee Enterprises (APOG) a company with “yuge” profit potential. Founded in 1949 and headquartered in Minneapolis, Minnesota, APOG designs and develops glass solutions for commercial buildings.

Top 10 Casino Stocks To Watch For 2018: Roche Holding AG (RHHBY)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    Keytruda is also picking up indications, trading up Thursday on news of a new FDA approval in front line lung cancer treatment (not a big surprise, but there was some doubt). Some adverse news on Roche’s (OTCQX:RHHBY) I-O competitor Tecentriq in bladder cancer led IBD to publish this:

  • [By SEEKINGALPHA.COM]

    Medtronic operates both in the therapeutic and diagnostic medical markets throughout the world; the company’s varied product lines face a vast combination of competitors, ranging from large manufacturers with multiple business lines (exemplified by Johnson & Johnson) to smaller manufacturers offering a limited selection of products, like Insulet (NASDAQ:PODD). Other notable competitors include Abbott Labs (NYSE:ABT), C.R. Bard (NYSE:BCR), Baxter (NYSE:BAX), LivaNova (NASDAQ:LIVN), Roche (OTCQX:RHHBY), DexCom (NASDAQ:DXCM) and Tandem (NASDAQ:TNDM).

  • [By Ben Levisohn]

    We expect a strong 2017 performance from Keytruda in NSCLC, though revenue and EPS estimates are now 2%-7% and 5%-12% below consensus between 2017E-20E. We also expect further pressure on Keytruda in 2018, driven by share losses in first-line non-small cell lung cancer to Bristol-Myers Squibb (BMY), AstraZeneca (AZN) and Roche (RHHBY) as well as an increasing overhang from the Januvia/ Janumet patent expiries as they loom ever closer. Merck screens poorly on many valuation metrics to us and we have downgraded the shares to Underperform.

  • [By SEEKINGALPHA.COM]

    There’s still a lot to love about BMY and Opdivo, as they have the potential to be much larger. Now, notable BMY buyers could be the likes of Novartis (NYSE:NVS), Roche (OTCQX:RHHBY) or Pfizer (NYSE:PFE) – PFE has been looking to up its presence in the oncology market, and is also looking for a major purchase. BMY has a strong oncology pipeline that could work well with PFE or even Gilead (NASDAQ:GILD). GILD has an interest in oncology, and has plenty of cash for a buyout.

Top 10 Casino Stocks To Watch For 2018: Dermira, Inc.(DERM)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Current market dynamics, particularly in the SMID biotech universe, provide a plethora of opportunities for the company to augment the breadth and depth its pipeline in its core therapeutic areas, including neurology, ophthalmology and dermatology, where innovation is rife and where consolidation of some of the smaller players in the space is likely, in our view. Stocks in our SMID coverage universe that could potentially constitute future acquisition targets forAllergan include Aclaris Therapeutics (ACRS) and Dermira (DERM) (both have mid- to late-stage dermatology assets in development). We note with interest the collaboration with Heptares announced yesterday evening for the development of several M1, M4 and dual M1/M4 agonists in development for a variety of neurological diseases, including Alzheimers disease. Notwithstanding this above, larger scale transactions of course cannot be ruled out, and we note todays market commentary (Fox Business) regarding the potential sale of Valeant Pharmaceuticals International’s (VRX) Bausch & Lomb unit. It is reasonable to assume thatAllergan could be a bidder for this asset, given the companys presence in ophthalmology, as well as CEO Brent Saunders familiarity with the asset (he was the CEO prior to its sale toValeant in 2013 for $8.7bn). At the time of its sale to Valeant, B&L was generating c.$3bn in revenues and growing at a double-digit rate. Current sales of the asset are unclear due to the reporting structure of Valeant, as well as concerns regarding the companys operating/ pricing strategy.